Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 4/20 | 0.58 |
| ▸ | CA2 | P00918 | 4/20 | 0.58 |
| ▸ | CA7 | P43166 | 3/20 | 0.58 |
| ▸ | CA9 | Q16790 | 3/20 | 0.58 |
| ▸ | CA12 | O43570 | 2/20 | 0.58 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.58 |
| ▸ | CA4 | P22748 | 1/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.50 |
| ▸ | TP53 | P04637 | 2/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.50 |
| ▸ | MAPT | P10636 | 2/20 | 0.50 |
| ▸ | HPGD | P15428 | 2/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.50 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.50 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.50 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25874735 | 0.92 | CA1 (0.50) | CA1CA2CA7CA9CA12 | |
| SCHEMBL16590519 | 0.87 | CA1 (0.50) | CA1CA2CA7CA9CA12 | |
| SCHEMBL4136425 | 0.87 | CA1 (0.50) | CA1CA2CA7CA9CA12 | |
| SCHEMBL12311883 | 0.85 | CA1 (0.48) | CA1CA2CA7CA9CA12 | |
| SCHEMBL30918934 | 0.85 | CA1 (0.48) | CA1CA2CA7CA9CA12 | |
| SCHEMBL16257301 | 0.84 | NPSR1 (0.42) | CA1CA2CA7CA9CA12 | |
| SCHEMBL19573863 | 0.84 | SMN1; SMN2 (0.45) | CA1CA2CA7CA9CA12 | |
| SCHEMBL23885410 | 0.83 | ALDH1A1 (0.60) | CA1CA2CA7CA9CA12 | |
| SCHEMBL2045969 | 0.83 | MAPT (0.64) | CA1CA2CA7CA9CA12 | |
| SCHEMBL4185526 | 0.83 | CA1 (0.46) | CA1CA2CA7CA9CA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 181 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115894184-B | Method for preparing di (2, 6-dimethoxy phenyl) triethylene glycol | 黎明化工研究设计院有限责任公司 | 2024-07-05 | — | — | CN | claimed |
| CN-113087689-B | Simple synthesis method of 5-amino-gamma-lactone derivative | 中国人民解放军空军军医大学 | 2023-09-29 | — | — | CN | claimed |
| CN-115894184-A | Method for preparing di (2, 6-dimethoxyphenyl) triethylene glycol | 黎明化工研究设计院有限责任公司 | 2023-04-04 | — | — | CN | claimed |
| CN-110981838-B | 5-imine-tetrahydrofuryl methylamine derivative and preparation method and application thereof | 中国人民解放军第四军医大学 | 2023-03-24 | — | — | CN | claimed |
| CN-113087689-A | Simple synthesis method of 5-amino-gamma-lactone derivative | 中国人民解放军空军军医大学 | 2021-07-09 | — | — | CN | claimed |
| CN-106748604-B | Method for synthesizing mono-iodo aromatic hydrocarbon or di-iodo aromatic hydrocarbon based on decarboxylation of aromatic carboxylic acid | 湘潭大学 | 2020-06-05 | — | — | CN | claimed |
| CN-110981838-A | 5-imine-tetrahydrofuryl methylamine derivative and preparation method and application thereof | 中国人民解放军第四军医大学 | 2020-04-10 | — | — | CN | claimed |
| CN-106748604-A | A kind of method for synthesizing single iodo aromatic hydrocarbon or two iodo aromatic hydrocarbons based on aromatic carboxylic acid's decarboxylic reaction | 湘潭大学 | 2017-05-31 | — | — | CN | claimed |
| US-20030069427-A1 | Process for the preparation of 5-(substituted)-10 methoxy-2,2,4-trimethyl-2,5-dihydro- 1H-chromeno [3,4-f] quinolines and derivatives thereof | ABBVIE INC. | 2003-04-10 | — | — | US | claimed |
| WO-2003027117-A1 | A PROCESS FOR THE PREPARATION OF 5-(SUBSTITUTED)-10-METHOXY-2,2,4-TRIMETHYL-2,5-DIHYDRO-1H-CHROMENO[3,4-F]QUINOLINES AND DERIVATIVES THEREOF | ABBOTT LABORATORIES (US) | 2003-04-03 | — | — | WO | claimed |
| US-6518430-B1 | The present invention relates to an efficient process for the preparation of 5-(substituted)-10-methoxy-2,2,4-trimethyl-2,5- dihydro-1H-chromeno(3,4-f)quinolines. | ABBOTT LABORATORIES | 2003-02-11 | — | — | US | claimed |
| US-20250243229-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2025-07-31 | — | — | US | disclosed |
| US-20250236621-A1 | 5- AND 6-AZAINDOLE COMPOUNDS FOR INHIBITION OF BCR-ABL TYROSINE KINASES | ENLIVEN INC. | 2025-07-24 | — | — | US | disclosed |
| CN-120040505-A | Phosphorus phenol ligand, phosphorus phenol complex, preparation method and application thereof, and ethylene polymerization method | 南开大学 | 2025-05-27 | — | — | CN | disclosed |
| US-12297212-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2025-05-13 | — | — | US | disclosed |
| WO-2003027117-A1 | A PROCESS FOR THE PREPARATION OF 5-(SUBSTITUTED)-10-METHOXY-2,2,4-TRIMETHYL-2,5-DIHYDRO-1H-CHROMENO[3,4-F]QUINOLINES AND DERIVATIVES THEREOF | ABBOTT LABORATORIES (US) | 2003-04-03 | — | — | WO | disclosed |
| US-6518430-B1 | The present invention relates to an efficient process for the preparation of 5-(substituted)-10-methoxy-2,2,4-trimethyl-2,5- dihydro-1H-chromeno(3,4-f)quinolines. | ABBOTT LABORATORIES | 2003-02-11 | — | — | US | disclosed |
| US-20010041674-A1 | C-glycosides and preparation of thereof as antidiabetic agents | KOTOBUJKI PHARMACEUTICAL CO., LTD. | 2001-11-15 | — | — | US | disclosed |
| US-4879398-A | Process for producing 2,6-disubstituted tyrosine | MONSANTO COMPANY (US) | 1989-11-07 | — | — | US | disclosed |
| US-3992273-A | Method of preparing substituted phenyl phosphinic acids | MONSANTO COMPANY (US) | 1976-11-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20010041674-A1 | C-glycosides and preparation of thereof as antidiabetic agents | GCG, SLC5A1, SLC5A2 | CA1 431/4885CA2 147/4885CA7 23/4885 |
| US-20250243229-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | F5, OR10J3, NPY4R | CA1 2594/4885CA2 2469/4885CA7 2325/4885 |
| US-20250236621-A1 | 5- AND 6-AZAINDOLE COMPOUNDS FOR INHIBITION OF BCR-ABL TYROSINE KINASES | ABL1, ABL2, BCR | CA1 4735/4885CA2 4223/4885CA7 3708/4885 |
| US-12297212-B2 | Organic electroluminescent materials and devices | OCIAD2, OCIAD1, OR10J3 | CA1 3917/4885CA2 3349/4885CA7 2050/4885 |
| US-20030069427-A1 | Process for the preparation of 5-(substituted)-10 methoxy-2,2,4-trimethyl-2,5-dihydro- 1H-chromeno [3,4-f] quinolines and derivatives thereof | HTR3C, CYP3A5, NQO2 | CA1 4803/4885CA2 4014/4885CA7 3313/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.